Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Juan Liu & Dawei Zang. (2009) Response of neural precursor cells in the brain of Parkinson's disease mouse model after LIF administration. Neurological Research 31:7, pages 681-686.
Read now
Read now
Makoto Naoi & Wakako Maruyama. (2009) Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson’s disease. Expert Review of Neurotherapeutics 9:8, pages 1233-1250.
Read now
Read now
José Martínez Orgado, Javier Fernández-Ruiz & Julián Romero. (2009) The endocannabinoid system in neuropathological states. International Review of Psychiatry 21:2, pages 172-180.
Read now
Read now
Articles from other publishers (38)
Jakub Sawicki, Rico Berner, Sarah A. M. Loos, Mehrnaz Anvari, Rolf Bader, Wolfram Barfuss, Nicola Botta, Nuria Brede, Igor Franović, Daniel J. Gauthier, Sebastian Goldt, Aida Hajizadeh, Philipp Hövel, Omer Karin, Philipp Lorenz-Spreen, Christoph Miehl, Jan Mölter, Simona Olmi, Eckehard Schöll, Alireza Seif, Peter A. Tass, Giovanni Volpe, Serhiy Yanchuk & Jürgen Kurths. (2023) Perspectives on adaptive dynamical systems. Chaos: An Interdisciplinary Journal of Nonlinear Science 33:7.
Crossref
Crossref
Luke Andrews, Simon S Keller, Jibril Osman-Farah & Antonella Macerollo. (2023) A structural magnetic resonance imaging review of clinical motor outcomes from deep brain stimulation in movement disorders. Brain Communications 5:3.
Crossref
Crossref
Ziqing Wei, Mingze Wei, Xiaoyu Yang, Yuming Xu, Siqi Gao & Kaidi Ren. (2022) Synaptic Secretion and Beyond: Targeting Synapse and Neurotransmitters to Treat Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2022, pages 1-22.
Crossref
Crossref
Shelby Loraine Hatton & Manoj Kumar Pandey. (2022) Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s Disease. International Journal of Molecular Sciences 23:3, pages 1089.
Crossref
Crossref
Juan A. Parga, Ana I. Rodriguez-Perez, Maria Garcia-Garrote, Jannette Rodriguez-Pallares & Jose L. Labandeira-Garcia. (2021) NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin. Antioxidants 10:11, pages 1649.
Crossref
Crossref
Isadora Olivé, Nikos Makris, Maria Densmore, Margaret C. McKinnon & Ruth A. Lanius. (2021) Altered basal forebrain BOLD signal variability at rest in posttraumatic stress disorder: A potential candidate vulnerability mechanism for neurodegeneration in PTSD. Human Brain Mapping 42:11, pages 3561-3575.
Crossref
Crossref
Raghavendra Upadhya & Ashok K Shetty. (2021) Extracellular Vesicles for the Diagnosis and Treatment of Parkinson’s Disease. Aging and disease 12:6, pages 1438.
Crossref
Crossref
Ilaria Rosa, Davide Di Censo, Brigida Ranieri, Giuseppe Di Giovanni, Eugenio Scarnati, Marcello Alecci, Angelo Galante & Tiziana Marilena Florio. (2020) Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA Hemiparkinsonian Rats. International Journal of Molecular Sciences 21:8, pages 2874.
Crossref
Crossref
Giuseppe Di Giovanni, Laura Clara Grandi, Ernesto Fedele, Gergely Orban, Agnese Salvadè, Wei Song, Eleonora Cuboni, Alessandro Stefani, Alain Kaelin-Lang & Salvatore Galati. (2020) Acute and Chronic Dopaminergic Depletion Differently Affect Motor Thalamic Function. International Journal of Molecular Sciences 21:8, pages 2734.
Crossref
Crossref
Laura Clara Grandi, Giuseppe Di Giovanni & Salvatore Galati. (2018) Reprint of “Animal models of early-stage Parkinson's disease and acute dopamine deficiency to study compensatory neurodegenerative mechanisms”. Journal of Neuroscience Methods 310, pages 75-88.
Crossref
Crossref
Laura Clara Grandi, Giuseppe Di Giovanni & Salvatore Galati. (2018) Animal models of early-stage Parkinson’s disease and acute dopamine deficiency to study compensatory neurodegenerative mechanisms. Journal of Neuroscience Methods 308, pages 205-218.
Crossref
Crossref
Giuseppe Di Giovanni, Vincenzo Crunelli & Giacomo Rizzolatti. (2018) Interdisciplinary approaches for neuropathology. CNS Neuroscience & Therapeutics 24:8, pages 665-668.
Crossref
Crossref
Philippe De Deurwaerdère, Giuseppe Di Giovanni & Mark J. Millan. (2017) Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry. Progress in Neurobiology 151, pages 57-100.
Crossref
Crossref
Philippe De Deurwaerdère & Giuseppe Di Giovanni. (2017) Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications. Progress in Neurobiology 151, pages 175-236.
Crossref
Crossref
Giuseppe Di Giovanni & Philippe De Deurwaerdère. (2016) New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders. Pharmacology & Therapeutics 157, pages 125-162.
Crossref
Crossref
Julie K. Andersen & Shankar Chinta. 2016. Advances in Geroscience. Advances in Geroscience
229
255
.
Oytun Erbaş, Bilge Piri Çınar, Volkan Solmaz, Türker Çavuşoğlu & Utku Ateş. (2015) The neuroprotective effect of erythropoietin on experimental Parkinson model in rats. Neuropeptides 49, pages 1-5.
Crossref
Crossref
N. A. Sinyakova & A. V. Kulikov. (2014) Expression of genes in the 111.35–116.16 million bp fragment of chromosome 13 in brain of mice with different predisposition to hereditary catalepsy. Molecular Biology 48:5, pages 638-645.
Crossref
Crossref
Jun Ming Wang. (2014) Allopregnanolone and neurogenesis in the nigrostriatal tract. Frontiers in Cellular Neuroscience 8.
Crossref
Crossref
Sylvia Navailles, Léa Milan, Hanane Khalki, Giuseppe Di Giovanni, Mélanie Lagière & Philippe De Deurwaerdère. (2014)
Noradrenergic Terminals Regulate
l
‐
DOPA
‐derived Dopamine Extracellular Levels in a Region‐dependent Manner in Parkinsonian Rats
. CNS Neuroscience & Therapeutics 20:7, pages 671-678.
Crossref
Crossref
Sylvia Navailles, Giuseppe Di Giovanni & Philippe De Deurwaerdère. (2014)
Predicting Dopaminergic Effects of
L
‐
DOPA
in the Treatment for
P
arkinson's Disease
. CNS Neuroscience & Therapeutics 20:7, pages 699-701.
Crossref
Crossref
William M. Connelly, Adam C. Errington, Josue G. Yagüe, Anna Cavaccini, Vincenzo Crunelli & Giuseppe Di Giovanni. 2014. Extrasynaptic GABAA Receptors. Extrasynaptic GABAA Receptors
125
153
.
Fabrizio Gasparini, Thérèse Di Paolo & Baltazar Gomez-Mancilla. (2013) Metabotropic Glutamate Receptors for Parkinson's Disease Therapy. Parkinson's Disease 2013, pages 1-11.
Crossref
Crossref
Martin C. Herzig, Michael Bidinosti, Tatjana Schweizer, Thomas Hafner, Christine Stemmelen, Andreas Weiss, Simone Danner, Nella Vidotto, Daniela Stauffer, Carmen Barske, Franziska Mayer, Peter Schmid, Giorgio Rovelli, P. Herman van der Putten & Derya R. Shimshek. (2012) High LRRK2 Levels Fail to Induce or Exacerbate Neuronal Alpha-Synucleinopathy in Mouse Brain. PLoS ONE 7:5, pages e36581.
Crossref
Crossref
Derya R. Shimshek, Tatjana Schweizer, Peter Schmid & P. Herman van der Putten. (2012) Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1. Scientific Reports 2:1.
Crossref
Crossref
Martin C. Herzig, Carine Kolly, Elke Persohn, Diethilde Theil, Tatjana Schweizer, Thomas Hafner, Christine Stemmelen, Thomas J. Troxler, Peter Schmid, Simone Danner, Christian R. Schnell, Matthias Mueller, Bernd Kinzel, Armelle Grevot, Federico Bolognani, Martina Stirn, Rainer R. Kuhn, Klemens Kaupmann, P. Herman van der Putten, Giorgio Rovelli & Derya R. Shimshek. (2011) LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Human Molecular Genetics 20:21, pages 4209-4223.
Crossref
Crossref
Mercedes Unzeta & Elisenda Sanz. 2011. Monoamine Oxidase and their Inhibitors. Monoamine Oxidase and their Inhibitors
217
236
.
Salvatore Galati & Giuseppe Di Giovanni. (2010) Neuroprotection in Parkinson's Disease: a Realistic Goal?. CNS Neuroscience & Therapeutics 16:6, pages 327-329.
Crossref
Crossref
Giuseppe Di Giovanni. (2010) Dopamine Interaction with other Neurotransmitter Systems: Relevance in the Pathophysiology and Treatment of CNS Disorders. CNS Neuroscience & Therapeutics 16:3, pages 125-126.
Crossref
Crossref
Makoto Naoi, Wakako Maruyama, Hong Yi, Keiko Inaba, Yukihiro Akao & Masayo Shamoto-Nagai. (2009) Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. Journal of Neural Transmission 116:11, pages 1371-1381.
Crossref
Crossref
Massimo Pierucci, Vincenzo Di Matteo, Arcangelo Benigno, Giuseppe Crescimanno, Ennio Esposito & Giuseppe Di Giovanni. (2009) The Unilateral Nigral Lesion Induces Dramatic Bilateral Modification on Rat Brain Monoamine Neurochemistry. Annals of the New York Academy of Sciences 1155:1, pages 316-323.
Crossref
Crossref
Vincenzo Di Matteo, Massimo Pierucci, Arcangelo Benigno, Giuseppe Crescimanno, Ennio Esposito & Giuseppe Di Giovanni. (2009) Involvement of Nitric Oxide in Nigrostriatal Dopaminergic System Degeneration. Annals of the New York Academy of Sciences 1155:1, pages 309-315.
Crossref
Crossref
Giuseppe Giovanni, Ennio Esposito & Vincenzo Matteo. 2009. Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra. Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra
223
243
.
Vincenzo Matteo, Massimo Pierucci, Arcangelo Benigno, Gergely Orbán, Giuseppe Crescimanno, Ennio Esposito & Giuseppe Giovanni. 2009. Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra. Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra
173
182
.
Vincenzo Di Matteo, Massimo Pierucci, Arcangelo Benigno, Ennio Esposito, Giuseppe Crescimanno, Maurizio Casarrubea & Giuse Di Giovanni. 2009. The Basal Ganglia IX. The Basal Ganglia IX
309
321
.
Ken-ichi Fujita & Srinivasa M. Srinivasula. 2009. Death Receptors and Cognate Ligands in Cancer. Death Receptors and Cognate Ligands in Cancer
87
114
.
Alberto Halabe Bucay. (2008) Activation of the Proopiomelanocortin Gene with Ketoconazole as a Treatment for Parkinson's Disease. Annals of the New York Academy of Sciences 1144:1, pages 237-242.
Crossref
Crossref
M. Jimenez-Del-Rio, A. Daza-Restrepo & C. Velez-Pardo. (2008) The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: Implications in Parkinson's disease. Neuroscience Research 61:4, pages 404-411.
Crossref
Crossref